297
Progression level of extracapsular spread and tumour
budding for cervical lymph node metastasis of oral
squamous cell carcinoma
S. Yamada
∗
, M. Otsuru, S. Yanamoto, T. Hasegawa,
H. Aizawa, T. Kamata, N. Yamakawa, T. Kohgo, A. Ito,
Y. Noda, C. Hirai, T. Kitamura, M. Okura, T. Kirita, M. Ueda,
T. Yamashita, Y. Ota, T. Komori, M. Umeda, H. Kurita
Department of Dentistry and Oral Surgery, Shinshu University
School of Medicine, Matsumoto, Japan
Background:
The extracapsular spread (ECS) of cervical lymph
node metastasis was identified as a strong prognostic factor in oral
squamous cell carcinoma (OSCC) patients at a high risk of recur-
rence. Tumour budding was reported to be correlated with poor
prognosis and lymph node metastasis including occult metastasis.
Objectives:
The aim of the present study was to investigate the
efficacy of tumour budding on the prognosis, and to analyse the
association between progression level of ECS and tumour buss-
ing in OSCC patients based on large number of patients with a
multicentre retrospective analysis.
Methods:
The Kaplan–Meier method was used to examine overall
survival (OS) and relapse-free survival (RFS) curves. Prognosis
factor for recurrence was analysed with univariate andmultivariate
analysis.
Findings:
ECS was detected in 216 cases and analysed. The five-
year overall survival and RFS rates of patients with Type C, which
was microscopically defined as tumour invasion to perinodal fat
or muscle tissue, were significantly poor at 40.6% and 37.8%,
respectively. The results of a univariate analysis suggested that
the prognosis of ECS in OSCC patients is associated with its pro-
gression level, particularly Type C. The five-year RFS rate of Type
C with tumour budding was significantly poor at 31.5%. Type C
with tumour budding correlated with local and regional recurrence
as well as distant metastasis. In a multivariate analysis, tumour
budding was identified as an independent prognostic factor.
Conclusion:
These results suggest that the progression level of
ECS and tumour budding are useful prognostic factors in OSCC
patients.
http://dx.doi.org/10.1016/j.ijom.2017.02.998Maxillary ameloblastoma: factors associated with risk of
recurrence
R. Yang
∗
, Z.Q. Liu, C.B. Peng, W. Cao, T. Ji
Department of Oral and Maxillofacial – Head and Neck
Oncology, Ninth People’s Hospital, Shanghai Jiao Tong
University School of Medicine, China
Objective:
Maxillary ameloblastomas are rare and associatedwith
an aggressive course because of the anatomical composition of the
maxilla and adjacent structures. The risk factors associated with
recurrence were analysed in this retrospective study.
Subjects and Methods:
Cases of maxillary ameloblastoma
reported in a tertiary hospital from 2005 to 2015 were analysed
to identify clinicopathological and radiological factors associated
with recurrence using univariate and multivariate Cox regression
analyses.
Results:
A total of 890 patients with ameloblastomas were
treated in this study, of whom only 51 (5.7%) had maxillary
ameloblastomas. The median follow-up period was 56
±
28.65
months. Of the maxillary ameloblastomas, 29 (56.8%) were pri-
mary and 22 (43.1%) were recurrent. Soft tissue or maxillary sinus
invasion and primary or recurrent tumour status were risk factors
significantly associated with recurrence in the univariate analyses
(
P
= 0.006 versus
P
= 0.025, respectively), while the association
between recurrence and surgical methods was borderline signifi-
cant (
P
= 0.08). The multivariate Cox regression analysis showed
that soft tissue or maxillary sinus involvement was significantly
associated with recurrence (
P
= 0.023).
Conclusion:
Recurrent tumours and tumours with soft tissue
or maxillary sinus involvement were risk factors for recurrence
among maxillary ameloblastoma patients.
http://dx.doi.org/10.1016/j.ijom.2017.02.999The effect and molecular mechanism of TSP-1 on biological
behaviour of mucoepidermoid cancer
S. Yang
∗
, L. Guo, P. Ji, J.L. Song, X.Y. Wang, X.F. Tang
Suining Central Hospital, China
Background:
Mucoepidermoid cancer (MEC) is one of the malig-
nant tumours of salivary gland. Some researches have proved that
function of TSP-1 on tumour only by inhibition of angiogenesis,
but had no effect on tumour cells.
Objectives:
This article explores the impact of TSP-1 on bio-
logical behaviour of MEC and provides some references on the
mechanisms of development and metastasis of MEC.
Methods:
Immunofluorescence (IFC) andWestern Blot were used
to detect expression of TSP-1, CD36 and CD47 of MEC to choose
the most suitable experimental object. MTT was used to detect
the effect of TSP-1 on proliferation of MEC. Transwell was per-
formed to investigate the ability change of invasion. Cell cycle
was evaluated by flow cytometry and IFC experiments.
Findings:
Poorly differentiated MEC which reduced expression
TSP-1 and the same time express CD36 and CD47 as experimental
object. Cell growth rate ability of TSP-1, CD36 and CD47 group is
obviously slower then the control. Transwell showed the number
of TSP-1 group cells dramatically decreased, there is no significant
differences between CD47 blocked and TSP-1 group. Early apop-
totic cell number of TSP-1 group was dramatically higher than the
CD47 blocked and control group, but no significant differences
with CD36 blocked.
Conclusions:
TSP-1 dramatically inhibit proliferation of MEC
by combining with CD36 not CD47. TSP-1 inhibits invasive abil-
ity of MEC, which is closely rated with CD36. TSP-1 is mainly
combined with CD47 to induce MEC apoptosis.
http://dx.doi.org/10.1016/j.ijom.2017.02.1000Detection of genome mutations in high risk oral pre-cancer
lesions
E.H. Yu
∗
, H.F. Tu
National Yang-Ming University Hospital, Yilan, Chinese Taipei
Background:
The progression of oral cancer includes a period
of pre-cancer lesion, or oral potentially malignant disorders
(OPMD). The malignant transformation rate of OPMD is about




